FDA
-
-
-
-
-
-
-
STAAR Surgical Reports First Quarter 2026 Results; Issues Shareholder Letter
-
-
-
-
-
-
-
FDA Expands U.S. Age Indication for EVO ICL as Long-Term Safety Data Reinforces Market Shift Away From Laser Vision Correction
-
-
-
-
-
-
-
STAAR Surgical Announces $30 Million Share Repurchase Authorization
-
-
-
-
-
-
-
STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024
-
-
-
-
-
-
-
Professional Basketball Player Max Strus Kicks Off New Season With Upgraded Vision From Life-Changing EVO ICL Lenses
-
-
-
-
-
-
-
STAAR Surgical Announces U.S. FDA Approval of EVO VisianĀ® Implantable CollamerĀ® Lenses
-
-
-
-
-
-
-
STAAR Surgical Reports Record First Quarter 2021 Net Sales of $50.8 Million Up 44% Y/Y
-
329,754 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

